Bioz and Covaris Expand Their Partnership to Accelerate the Pace of Life Science Research and Drug Discovery

Press Release
July 9, 2019

LOS ALTOS, Calif., July 9, 2019 /PRNewswire/ — Bioz, Inc., a Silicon Valley AI data company, is proud to announce the expansion of its partnership with Covaris, the world leader in pre-analytical sample preparation technologies. Covaris has developed proprietary and patented Adaptive Focused Acoustics® (AFA®) technology. AFA enables a vast array of non-contact, isothermal processes to be developed for use in a broad range of applications in genomics, epigenomics, proteomics, cell biology, drug discovery, and formulation. Covaris is the market leader and gold standard for DNA fragmentation for Next Generation Sequencing. Covaris AFA technology also lyses a variety of cell and tissue types while providing the highest quality active extraction and standardization of nucleic acid and protein sample preparation. Thousands of Covaris focused-ultrasonicators are in use globally, and customers include the world’s leading researchers, universities, sequencing centers, and pharmaceutical companies.

Read the full Press Release on